Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin

The use of botulinum neurotoxin serotype A (BoNT-A) injections for the treatment of orofacial dyskinesia secondary to anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is rarely reported. Here, we report a case of an urgent, successful management of severe orofacial dyskinesia in an 8-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Feixia, Ye, Xiuyun, Shi, Xulai, Poonit, Neha Devi, Lin, Zhongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827093/
https://www.ncbi.nlm.nih.gov/pubmed/29520252
http://dx.doi.org/10.3389/fneur.2018.00081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827093/
https://www.ncbi.nlm.nih.gov/pubmed/29520252
http://dx.doi.org/10.3389/fneur.2018.00081

Ejemplares similares